Johnson & Johnson vs Opendoor Technologies Inc — how do they compare? Johnson & Johnson trades at $259.8 (market cap $630.94B), while Opendoor Technologies Inc trades at $3.58 (market cap $3.36B). The key difference: Johnson & Johnson is far larger — about 187.8× Opendoor Technologies Inc's market cap, and Johnson & Johnson pays a 2.05% dividend while Opendoor Technologies Inc pays none. Which is the better fit depends on your goals.
| JNJ | OPEN | |
|---|---|---|
Market Cap | $630.94B | $3.36B |
Volume | 6,156,228 | — |
Sector | Health | Real Estate |
52-Week High | $267.24 | $10.52 |
52-Week Low | $172.78 | $2.42 |
Enterprise Value | $659.21B | $4.43B |
Dividend Yield | 2.05% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $259.24, up 0.88% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $282.33. Recent earnings beat expectations in Q1 and Q2 2026, with Q3 results pending. The company maintains strong profitability, including a 67.91% gross margin and 21.48% net income margin, supported by consistent dividend payments, including a recent $1.34 per share payout.
JNJ offers stability with a 64-year dividend growth streak and robust fundamentals, but risks include rising debt-to-asset ratios (24.06% in 2025) and sector volatility. Upside potential hinges on execution of growth initiatives and healthcare market dynamics, with analysts favoring a buy rating (52.5% consensus).
Opendoor Technologies (OPEN) trades at $3.485, up 1.16% on the day, but remains in a bearish technical trend with weak fundamentals. Revenue has declined from $15.6B in 2022 to $4.37B in 2025, with persistent net losses and a negative net income margin of -46.74%. Recent Q2 2026 earnings missed expectations, and cash flow volatility adds to operational challenges. The stock faces headwinds from a sluggish housing market and high interest rates, as reflected in negative analyst sentiment and a consensus price target of $3.58.
The outlook for OPEN is cautious due to ongoing losses, competitive pressures, and macroeconomic uncertainty. While the low P/S ratio of 0.95 may attract value seekers, significant execution risk and debt levels pose threats. Investor sentiment is predominantly bearish, with 65% of analysts rating Hold. Recovery hinges on sustainable margin improvement and housing market stabilization, but near-term volatility is expected.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →